Q2 2023 Medipharm Labs Corp Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the MediPharm Labs' 2023 second-quarter financial results conference call. Please be advised that today's conference is being recorded. Before we begin, please note that remarks today may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws. This includes, without limitation, statements about MediPharm Labs and its current and future plans, expectations, intentions, financial results, levels of activity, performance, goals or achievements, and other future events, trends or developments, statements about MediPharm's acquisition of VIVO Cannabis Incorporated, the combined company's future financial and operational performance, the combined company's key business segments, product offerings, pro forma, and overall financial performance, potential revenue and cost synergies resulting from the transaction and statements about combined company's profitability and ability to grow the business going forward.
Forward-looking statements are made as of the date hereof based on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |